From the FDA Consumer Magazine, March-April 2005 by Carol Rados
Few people with arthritis would be willing to stop taking a medication that works, especially when nothing else has. But what if joint pain and stiffness are inevitable if you don't take the medication, yet heart problems could occur if you do? Health officials say that, as with any drug, only you and your doctor can determine the level of risk that is acceptable with medications currently available to treat arthritis.
The...
Read moreIt is very common for a woman with rheumatoid arthritis to suffer a disease flare within three months of the delivery of the baby. ... Read more »
Many years ago, the tobacco industry was told to cease and desist: No more advertising on television for cigarettes. It endangered... Read more »
Recently, the pharmaceutical company Amgen (the makers of Enbrel) announced that the results of a Phase 3 trial had been published... Read more »
The American College of Rheumatology Annual Scientific Meeting in Boston last week provided more good data on the new-and... Read more »
When a rheumatologist treats a patient with rheumatoid arthritis, the focus will naturally be on the joints: Are they swollen? Are they... Read more »
Q: How do most patients get referred to a rheumatologist in the first place?Kremer: Usually, it’s the pain that’s perceived to be arthritis pain.... Read more »
Read the full text of Fatigue: RA's Inconvenient Truth and leave a comment! See all of Sara's Comics Visit The Single Gal's Guide to Rheumatoid... Read more »
Source: Medifocus Guidebook on: Rheumatoid Arthritis
Goals of Treatment for Rheumatoid ArthritisThe primary goals of treatment for rheumatoid arthritis (RA) include: Alleviating joint-related symptoms... Read more »
A new rheumatoid arthritis (RA) medication being tested by Regeneron Pharmaceuticals and Sanofi has shown positive results in a recent clinical... Read more »
A review of previous studies has found a link between the use of tumor necrosis factor (TNF) inhibitors such as Remicade (infliximab), Enbrel... Read more »